Slideshow

Early Diagnosis and Treatment of Lupus Essential in Racial/Ethnic Populations

A study published last month in Arthritis Care & Research shows that racial/ethnic minorities disproportionately have more severe cases of systemic lupus erythematosus (SLE). In this slideshow, we summarize the findings, but we'd like to know what you think. Email us your comments at areyes@mmhgroup.com.

A study published last month in Arthritis Care & Research shows that racial/ethnic minorities disproportionately have more severe cases of systemic lupus erythematosus (SLE). In this slideshow, we summarize the findings.Although there were a number of limitations associated with study, such as incomplete medical records in some cases, the analysis demonstrates some obvious differences in terms of the severity of disease and clinical manifestations among black, Hispanic and Asian patients. However, in factoring the findings, the authors accounted for risk factors including sex, age at diagnosis and disease duration.The authors of the study suggest some solutions, but the editors of Rheumatology Network woud like to know your thoughts as a healthcare provider. If you have recommendations for improving the  gap in healthcare outcomes described in this study, please share them with us by emailing the editor.See related article:  "Lupus is More Severe in Racial/Ethnic Minorities" REFERENCEManingding E, Dall’Era M, Turpin L, Murphy L, Yazdany J, Racial/Ethnic Differences in Prevalence of and Time to Onset of SLE Manifestations: The California Lupus Surveillance Project (CLSP), Arthritis Care & Research (2019), doi: 10.1002/acr.23887

Related Videos
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
Laure Gossec, MD, PhD: Informing Physician Treatment Choices for Psoriatic Arthritis
Søren Andreas Just, MD, PhD: Developing AI to Mitigate Rheumatologist Shortages for Disease Assessment
Shreena K. Gandhi, MBBS: Recognizing Fibromyalgia as a Continuous Variable, Trait Diagnosis
Reducing Treatment Burden of Pegloticase for Uncontrolled Gout, with Orrin Troum, MD
Exploring CAR T-cell Therapy for Rheumatic/Autoimmune Diseases With Georg Schett, MD
John Stone, MD, MPH: Inebilizumab Efficacious for IgG4-Related Disease in MITIGATE Study
Uncovering the Role of COVID-19 in Rheumatic Disease, with Leonard Calabrese, DO
© 2024 MJH Life Sciences

All rights reserved.